Amneal Pharmaceuticals
AMRX
AMRX
154 hedge funds and large institutions have $200M invested in Amneal Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 51
37% less capital invested
Capital invested by funds: $316M → $200M (-$116M)
64% less call options, than puts
Call options by funds: $393K | Put options by funds: $1.08M
Holders
154
Holding in Top 10
1
Calls
$393K
Puts
$1.08M
Top Buyers
| 1 | +$2.16M | |
| 2 | +$1.87M | |
| 3 | +$1.37M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$972K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$944K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$1.44M | |
| 3 | -$1.27M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.18M |
| 5 |
State Street
Boston,
Massachusetts
|
-$962K |